您的位置: 首页 > 农业专利 > 详情页

1-(4-(benzylbenzamid0) -benzyl) azetidine-3-carboxylic acid derivatives and related compounds as SlP receptor modulators for the treatment of immune disorders
专利权人:
Epix Pharmaceuticals, Inc.;Amgen Inc.
发明人:
Neira, Susana C.,Yu, Xiang,Burli, Roland,Cee, Victor,Lanman, Brian
申请号:
AU2008302746
公开号:
AU2008302746B2
申请日:
2008.09.19
申请国别(地区):
AU
年份:
2014
代理人:
摘要:
The present invention relates to amides that have activity as SlP receptor modulatingagents and the use of such compounds to treat diseases associated with inappropriateSlP receptor activity. The compounds may be used as immunomodulators, e.g.,for treating or preventing diseases such as autoimmune and related immune disordersincluding systemic lupus erythematosus, inflammatory bowel diseases suchas Crohn's disease and ulcerative colitis, type I diabetes, uveitis, psoriasis,myasthenia gravis, rheumatoid arthritis, non- glomerular nephrosis, hepatitis,Behcet's disease, glomerulonephritis, chronic thrombocytopenic purpura,hemolytic anemia, hepatitis and Wegner's granuloma; and for treatingother conditions.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充